Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance

In aged skin, local () and wider spread could sustain inflammation despite restored . Measured must predict recurring , while an remains stable.

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Not enough research data
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Biological function

Extracellular signalling in skin couples local interleukin-1 amplification to induction of its receptor antagonist. The mediators' effective spatial ranges and response kinetics govern the distribution of inflammatory activity within the tissue.Spatial regulation of inflammation

Direction

Lens

Puts the cause in what the system senses and how that signal is held and passed on, rather than in what it is made of.Information and sensing

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Goal
Damage–Repair Reinforcement and Post-Injury Persistence Suppression
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
Not ratedSupport from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Signalling molecule

    Interleukin-1α

    A signalling protein involved in inflammatory responses

    Where this hypothesis actsSkin under repeated despite normalized

    Hypotheses on this target 3
    Interleukin-1αLower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Neutralisation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 11
    • Lower level
    • Synthesis suppression
    • Neutralisation1
    • Supplementation
    • Accelerated excretion1

    What is proposed

    Spatially equalize while preserving its mean concentration

    With whatPhysical or surgical intervention

    HowSpatially equalize while matching mean concentrations; must preserve hydration, , mean exposure, and

    Possible result

    Possible suppression of and recurrent damage

    From the recordlocal IL-1 amplification induces a more widely distributed IL-1 receptor antagonist response

  2. Signalling molecule

    A protein that antagonizes receptor signalling

    Where this hypothesis actsSkin under repeated despite normalized

    Hypotheses on this target 2
    Interleukin-1 receptor antagonistLower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Neutralisation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 11
    • Lower level
    • Synthesis suppression
    • Neutralisation
    • Supplementation
    • Accelerated excretion1

    What is proposed

    Spatially equalize the while preserving its mean concentration

    With whatNot stated in the record

    HowAlter distribution and spatially equalize while matching their mean concentrations

    Possible result

    Possible stabilization of the inflammatory circuit and suppression of -damage recurrence

    From the recordIndependently measured reaction and diffusion parameters predict that frequency and its change when inhibitor distribution is altered.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTInterleukin-1α. Hypotheses on this target 3Interleukin-1αInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonist
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Aged skin might keep returning to a damaged state even after its ability to remove dead cells has recovered. The unexpected move is to locate that persistence in the arrangement of signals outside cells: local inflammatory activity and a more widely spreading counter-signal could together sustain recurring patches of inflammation. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Aged supporting tissue is proposed to maintain conditions that let amplify local inflammatory activity.
  2. Local activity induces its receptor , which is proposed to spread its blocking effect farther.
  3. The measured rates of signal production, removal, and spreading must permit a switch from a stable evenly mixed state to growing spatial differences.
  4. Those differences are predicted to develop into inflammatory patches with a reproducible spacing despite restored dead-cell removal.
  5. The persistent signal pattern is proposed to sustain recurring damage to the and its supporting material.
  6. Redistributing the signals to eliminate the unstable spatial arrangement, while preserving their average concentrations, is predicted to stop recurrence.
A picture for it

Imagine a crowd in which shouting encourages nearby people to shout, while calls for quiet travel farther. Under particular conditions, noisy clusters could persist even though the same crowd would settle down if every voice reached everyone equally.

Where the picture breaks: The picture does not establish how skin signals spread or whether their measured interactions can actually create clusters. Those properties must be measured; local encouragement and wider suppression alone do not prove the proposed pattern will form.

  1. Master questionstep 01 of 04

    Aging human skin might be shifted into a lasting state of youthful function through a sufficient combination of changes to cells, the material surrounding them, the surroundings that support tissue-renewing cells, blood vessels, and nerves.

    Rests on: The goal is to identify which changes are necessary, which work together, and whether their effects can persist.

    Assumption

    The question treats a stable youthful functional state as a possible target. The supplied material does not establish that such a state is attainable or define the measurements that would identify it.

  2. Goal pillarstep 02 of 04

    Lasting recovery is pursued through damage–repair reinforcement and suppression of changes that persist after injury.

    Rests on: The master question requires a transition that can be maintained, making persistence after injury relevant to the goal.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Restoring dead-cell removal by , immune cells that engulf cellular material, might stop repeated damage to the skin's protective barrier and , the supporting material outside cells. Alternatively, aged , the tissue's supporting cells and surroundings, might restart that damage during repeated .

    Rests on: The preceding stage identifies persistent injury responses as a target, but does not explain why dead-cell removal and aged supporting tissue are the alternatives to examine.

    Leap

    The supplied preceding stages do not establish a reinforcing connection between barrier injury and damage, or why restoring dead-cell removal would interrupt it. The screened source does not supply those missing connections.

  4. Hypothesisstep 04 of 04

    Aged supporting tissue is proposed to sustain recurring inflammatory patches through local of , an inflammatory signal, and wider spread of , a molecule that blocks that signal's receptor. The proposed persistent state is an arrangement of signals outside cells, rather than a remaining permanently activated.

    Rests on: The preceding question explicitly allows aged supporting tissue to restart damage despite restored dead-cell removal. The endpoint develops that possibility into a proposed spatial mechanism, borrowing the , a mathematical account of patterns produced by local reinforcement and more widely spreading suppression.

    Stated in the chain

What is carried, and what is not. One screened source speaks to one component link: the 2014 study in Age (Dordrecht, Netherlands), S1, reports that blocking , a form of , largely prevented harmful effects of elevated , also called CCN1, on , a structural protein in the skin's supporting material, in work concerning chronically sun-exposed human skin; it does not establish signal spacing, spreading rates, normalized dead-cell removal, or recurring damage. The mathematical model supplies a basis for the spatial proposal, but nothing supplied establishes the biological sequence end to end.S1

Where the reasoning is carried by something unstated · 2
  • Master question. The question treats a stable youthful functional state as a possible target. The supplied material does not establish that such a state is attainable or define the measurements that would identify it.
  • Gap question. The supplied preceding stages do not establish a reinforcing connection between barrier injury and damage, or why restoring dead-cell removal would interrupt it. The screened source does not supply those missing connections. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Improved recovery after blocking an inflammatory signal could be mistaken for evidence that spatial caused the damage. General suppression of inflammation does not establish the proposed transition from stable uniform activity to growing spatial differences. What closes it: The test must establish stability in the and growth of a spatial pattern, with patch spacing and its response to altered distribution predicted from independently measured parameters. The specification explicitly makes failure of these conditions a rejection of this mechanism.
  • Mixing could suppress recurrence by changing water balance, physical forces, signal exposure, or cell survival rather than by removing the spatial pattern. What closes it: The specified must preserve hydration, fluid forces on the tissue, average signal exposure, and cell survival. Spatial measurements must also verify that the intervention actually equalized the signals.
  • Normal removal of dead cells could be read as excluding the rival explanations, even though it does not exclude removal of living but recoverable cells or inflammation sustained by fragments of damaged supporting material. What closes it: Distinguishing these explanations requires measuring loss of recoverable cells and the generation or activity of the proposed inflammatory fragments alongside the spatial signals. The supplied test specification does not describe controls that selectively interrupt those rival routes.

What would make this wrong. The proposed spatial mechanism is rejected if independently measured signal interactions and spreading fail to show an evenly mixed state that is stable while a spatial pattern can grow, even if blocking inflammation improves recovery. Its claimed role in recurrence would also fail if verified equalization of the signals leaves recurrence unchanged while average exposure, tissue conditions, cell survival, and restored dead-cell removal are maintained.

What it would change. If the proposal held, restoring dead-cell removal alone would not be sufficient for lasting recovery in the tested aged-skin system; the spatial behavior of inflammatory signals would also need to be controlled. Work toward stable youthful skin would have to consider where signals act, alongside their average amounts. Even a successful would not establish durable rejuvenation of aging human skin or identify the minimal changes required across cells, supporting tissue, blood vessels, and nerves. The proposed target is not defined in the supplied material, so its stabilization cannot be translated into a specified functional outcome.

Sources read · 1

6 literature searches, 10 full texts; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

Elevated cysteine-rich protein 61 (CCN1) promotes skin aging via upregulation of IL-1β in chronically sun-exposed human skin. · Age (Dordrecht, Netherlands) · 2014

“Blockade of IL-1β actions by IL-1 receptor antagonist largely prevents the deleterious effects of CCN1 on collagen homeostasis.”

Does not settle: It does not establish spatial diffusion patterns, IL-1/IL-1 receptor antagonist kinetics or effective ranges, corpse clearance, persistent inflammatory foci, macrophage activation state, recurrence, SPV_1, or whether restoring spatial stability terminates matrix-damage recurrence.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does restored dead-cell removal stop skin damage after repeated challenges, or can aged surrounding tissue restart it?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does restoring terminate , or does aged reinstate it despite normalized clearance during repeated ?

What this question is asking

The question concerns whether restoring dead-cell removal can produce lasting recovery in aging human skin. It asks whether , immune cells that clear dead cells, can interrupt a proposed cycle in which damage to the skin’s protective barrier and its supporting material reinforces further damage. The competing possibility is that aged , the surrounding support cells and material, restarts this cycle even while dead-cell removal remains normal during repeated to the barrier. The intended comparison is lasting recovery versus returning damage, measured through barrier , inflammation, and the arrangement of supporting material relative to young skin, ultimately over twenty years. The question assumes that this reinforcing cycle exists and that surrounding aged tissue might sustain it independently of defective clearance; the supplied sources do not establish that complete mechanism.

What the terms mean
Macrophage
An immune cell that can engulf dead cells and release signals affecting inflammation and repair. can adopt overlapping patterns of activity; repair-associated activity is not a guarantee of normal tissue restoration.
Corpse clearance or dead-cell clearance
Removal of dead cells by other cells, including . Restoring deficient clearance means bringing impaired removal back toward a reference level; increasing clearance does not by itself establish that this has happened.
Skin barrier and barrier sealing
The skin’s protective boundary and the restoration of its ability to separate the body from the outside environment. The supplied input does not specify how successful is measured.
Barrier challenge
An event that stresses or disrupts the skin’s protective boundary. The question specifies repeated but supplies no method, strength, or interval.
Stroma or supporting tissue
The support cells and surrounding structural material within tissue. Aged is an age-related tissue context, not one uniform cell type or a single established mechanism.
Extracellular matrix
Material outside and between cells that provides structural support. Its organization concerns how that material is arranged, which can differ between repaired tissue and a scar.
Barrier–matrix damage reinforcement
The proposed cycle in which barrier damage and disruption of supporting material help perpetuate one another, with inflammation connecting the steps. The supplied sources do not establish this complete cycle.
Inflammation and resolution
Inflammation is an immune response to injury or disturbance; is the process by which that response subsides. Reduced inflammation does not by itself demonstrate restored tissue organization or lasting recovery.
Neutrophil
A type of immune cell involved in the wound response. The supplied sources discuss both its removal by and its persistence in aged wounds.
Fibroblast
A support cell that helps produce and maintain . Fibroblasts are recipients of the altered communication described in S7.
Collagen
A structural protein in . S4 reports more orderly rebuilding, an outcome distinct from wound closure alone.
Scar formation
Repair that leaves altered supporting tissue rather than fully restoring the preceding tissue organization. S3 shows that increased dead-cell clearance can accompany this outcome.
Normal clearance and youthful recovery time ranges
Comparison standards for how effectively dead cells are removed and how quickly young skin recovers. The pipeline requires these standards but supplies no numerical definitions or measurement procedures.
What the question takes for granted
Premise only partly supported
is a controllable contributor to a self-reinforcing , and aged may sustain or reinstate that loop independently of clearance.

are immune cells that remove dead cells, while the protects the body and the surrounding support cells and material help maintain tissue structure. The assumption is that damage to these parts feeds back on itself, with aged support tissue potentially keeping that process going even after dead-cell removal is restored. If established, this would make continued clearance and continuing tissue damage separable explanations for whether recovery lasts.

The sources support narrower components: increased dead-cell clearance accompanies repair-supporting changes in S1, support cells influence inflammation and produce structural material in S5, and aged wounds show persistent inflammatory cells and altered communication with support cells in S7. These findings do not establish a self-reinforcing barrier– loop or show aged restarting it after clearance is normalized. The supplied material also does not substantiate the gap detail’s specific assertion that existing clearance evidence establishes human . Failure to establish these claims in the supplied sources does not show that they are false.S1S5S7

The same question asked without the part nothing read establishes:

  • After dead-cell removal is restored in aging skin, do barrier , inflammation, and supporting-tissue organization remain recovered through repeated ?
  • When dead-cell removal remains normal during repeated mild skin challenges, does recovery differ between aged and young surrounding support tissue?
What turns on the answer
  • Recovery persists while clearance stays normal Under the proposed mechanism, removing dead cells would interrupt enough of the inflammation-and-damage sequence for barrier and supporting-tissue organization to recover repeatedly. If recovery continued within the time ranges seen in young skin, without progressively easier recurrence, clearance restoration would have met those functional criteria over the observed period. This would not by itself establish that every feature of skin aging had reversed.
  • Damage returns despite normal clearance Normal dead-cell removal would coexist with renewed barrier failure, inflammation, or disordered supporting material, showing that clearance restoration was insufficient for lasting recovery. Aged surrounding tissue would be a possible explanation within the question’s proposed mechanism, but recurrence alone would not establish that tissue as the cause.
  • Clearance deteriorates and damage returns The intervention would have failed to maintain the condition needed to distinguish the two main alternatives. Returning damage could still depend on defective dead-cell removal, so this outcome would not establish that aged surrounding tissue restarts damage independently of clearance.
Why it matters

In the proposed cycle, failure of the protective barrier contributes to inflammation, inflammation disrupts supporting tissue, and that disruption makes barrier recovery harder. Removing dead cells could interrupt a contributing source of inflammation, allowing recovery to continue. However, the supplied sources associate increased clearance with both repair-supporting changes and scar formation, so improved clearance alone cannot establish recovery of normal tissue organization [S1, S3]. If surrounding aged tissue restarts damage despite continued clearance, treating clearance as sufficient would mistake an early improvement for a lasting change. Conversely, lasting recovery through repeated challenges would support the narrower conclusion that continuing aged-tissue effects did not restart the measured damage under those conditions.

What is already established

evidence supports human at ; is , without integrated repeated-challenge restoration.

What would have to be true

, inflammation, and organization recover within youthful windows, without increasing persistence or falling across repeated challenges and twenty-year follow-up.

What is missing

Whether restored clearance survives aged is unknown; cannot establish durable interruption of the .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Aged supports a : local induces a more widely distributed response, but their measured and permit persistent despite normalized . The maladaptive state resides in a pattern, not a permanently activated . Restoring of this circuit should stabilize and terminate the associated -damage recurrence.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

and : the . A is ∂a/∂t = D_a∇²a + s_a + αa²/h − μ_a a; ∂h/∂t = D_h∇²h + s_h + βa² − μ_h h, with h > 0. Here x is position in the skin plane; t is time; a is local concentration; h is local concentration; D_a and D_h are measured ; s_a and s_h are per tissue volume; α is the strength of under suppression; β is the ; μ_a and μ_h are ; describes lateral spatial spreading. All coefficients carry units consistent with measured concentrations. For J, require negative of J but a positive of J − k²diag(D_a,D_h) for some k > 0. The predicted is 2π/k_max, where k_max maximizes growth. [Gierer and Meinhardt, 1972](https://pure.mpg.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_3489341).

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

After and verified clearance normalization, emerge at a reproducible nonzero . Independently measured predict that frequency and its change when distribution is altered. Spatially equalizing while matching their mean concentrations suppresses recurrence; the corresponding remains stable. Failure to demonstrate plus growth of a rejects this , even if improves recovery.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable spatial patterns, parameter-dependent frequency changes, suppression under stated conditions, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, , , and permit and . must preserve hydration, , mean exposure, and . is an experimental requirement, not an assumed consequence of molecular size.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

After and verified clearance normalization, emerge at a reproducible nonzero . Independently measured predict that frequency and its change when distribution is altered. Spatially equalizing while matching their mean concentrations suppresses recurrence; the corresponding remains stable. Failure to demonstrate plus growth of a rejects this , even if improves recovery.

  • What would separate them

    Restored corpse clearance can worsen aged skin by removing recoverable living cells predicts: In , restoration increases of , before irreversible death. suppression of reversible prevents this loss and restores repeated-challenge while labelled remains unchanged. Protected must subsequently survive and contribute ; negative alone are insufficient. Absence of rescuable , particularly if interventions instead prevent recurrence, rejects this mechanism.

  • What would separate them

    Collagen fragments keep skin inflammation active after normal corpse clearance returns predicts: In a with normalized , production precedes recurrent and damage. Selective or suppresses recurrence, and measured-concentration restores it. Activity remains demonstrable in a lacking , unlike the proposed . Failure of / to control recurrence rejects this relay even if broad helps.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

0 of 1 cited studies could be located, and 0 of 0 figures are not carried by one that resolved.

CitationsNo citation resolvedFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

1 citation handle extracted; 3 Europe PMC searches run; 5 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.